As perioperative treatment strategies for early-stage NSCLC continue to evolve , oncology teams must navigate increasingly complex decisions in multidisciplinary care. Don't miss this live webinar and the opportunity to hear from expert faculty, including a thoracic surgeon and a medical oncologist, as they examine tumor board perspectives on integrating surgery and immunotherapy in resectable NSCLC. Join us as they review current evidence on neoadjuvant, adjuvant, and perioperative approaches, discuss biomarker-driven treatment selection, and explore strategies to mitigate treatment-related toxicities through coordinated, team-based care.